AbbVie (ABBV) insider trading

By person

25 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Richard A Gonzalez

Director

—

386,479

$96.62M

−0.6%

Azita Saleki-Gerhardt

EVP, Chief Operations Officer

—

197,794

$49.45M

+26.9%

Robert A. Michael

Chairman of The Board and CEO

—

178,737

$44.68M

+81.2%

Thomas C Freyman

Director

—

127,869

$31.97M

+1.8%

Jeffrey Ryan Stewart

EVP, Chief Commercial Officer

—

83,171

$20.79M

+36.5%

Nicholas Donoghoe

EVP, Chief Bus/Strat Officer

—

74,430

$18.61M

+29.6%

Roopal Thakkar

EVP, R&D and CSO

—

52,376

$13.09M

+43.9%

Glenn F Tilton

Director

—

51,564

$12.89M

+2.4%

Edward J Rapp

Director

—

45,964

$11.49M

+5.3%

Roxanne S Austin

Director

—

39,576

$9.89M

+6.2%

Scott T Reents

EVP, Chief Financial Officer

—

38,777

$9.69M

+151.3%

Robert J Alpern

Director

—

35,646

$8.91M

+3.5%

Frederick H Waddell

Director

—

30,076

$7.52M

+8.4%

William H.l. Burnside

Director

—

28,076

$7.02M

+9.0%

Brett J Hart

Director

—

20,590

$5.15M

+12.7%

Melody B Meyer

Director

—

17,616

$4.40M

+15.2%

Rebecca B Roberts

Director

—

14,846

$3.71M

+18.5%

Demetris D Crum

EVP, Chief HR Officer

—

7,914

$1.98M

+12.3%

Kevin K Buckbee

SVP, Controller

—

7,797

$1.95M

+33.7%

Timothy J. Richmond

EVP, Chief HR Officer

—

6,130

$1.53M

−55.7%

Perry C Siatis

EVP, GC and Secretary

—

4,619

$1.15M

−55.6%

Susan E Quaggin

Director

—

3,643

$910.75K

+175.6%

Jennifer L. Davis

Director

—

3,643

$910.75K

+175.6%

David Ryan Purdue

SVP, Controller

—

2,654

$663.50K

−41.1%

Thomas J Falk

Director

—

2,321

$580.25K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

AbbVie

What the insiders did No buying or selling

By person